Figure 5
Figure 5. Unlicensed KIR+NKG2A− NK cells after HSCT demonstrate functional competence. IFN-γ response to class I–negative 721.221 target cells was calculated relative to baseline for each inhibitory KIR in each of 3 TCD-HSCT donor-recipient pairs (nos. 10, 12, and 14) by the formula (NKG2A−KIR+IFN-γ+/NKG2A−KIR+)/(NKG2A−KIR−IFN-γ+/NKG2A−KIR−). The relative response of NK cells exclusively expressing specific inhibitory KIR was compared between the allograft donor and the patient at days +100 to +200 after HSCT. (A) CD94/NKG2A-negative NK cells exclusively expressing inhibitory KIR to self-HLA from patients at days +100 to +200 are slightly hyporesponsive compared with their donors (P = .02). (B) CD94/NKG2A-negative NK cells exclusively expressing inhibitory KIR to non-self HLA from patients demonstrate higher response compared with the donor (P < .01). The paired Student t test was performed to compute the P value for these comparisons.

Unlicensed KIR+NKG2A NK cells after HSCT demonstrate functional competence. IFN-γ response to class I–negative 721.221 target cells was calculated relative to baseline for each inhibitory KIR in each of 3 TCD-HSCT donor-recipient pairs (nos. 10, 12, and 14) by the formula (NKG2AKIR+IFN-γ+/NKG2AKIR+)/(NKG2AKIRIFN-γ+/NKG2AKIR). The relative response of NK cells exclusively expressing specific inhibitory KIR was compared between the allograft donor and the patient at days +100 to +200 after HSCT. (A) CD94/NKG2A-negative NK cells exclusively expressing inhibitory KIR to self-HLA from patients at days +100 to +200 are slightly hyporesponsive compared with their donors (P = .02). (B) CD94/NKG2A-negative NK cells exclusively expressing inhibitory KIR to non-self HLA from patients demonstrate higher response compared with the donor (P < .01). The paired Student t test was performed to compute the P value for these comparisons.

Close Modal

or Create an Account

Close Modal
Close Modal